Walter E. Aulitzky
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 66
- Chronic Myeloid Leukemia Treatments 37
- Acute Myeloid Leukemia Research 36
- Genetics 38
- Chronic Lymphocytic Leukemia Research 29
- Co-authors
- Heiko van der Kuip (39 shared papers)Simon Heine (5 shared papers)Justus Duyster (9 shared papers)Moshe Oren (11 shared papers)Kathrin Böpple (5 shared papers)Frank Eßmann (5 shared papers)Markus Kleih (6 shared papers)Meng Dong (5 shared papers)
- Journals
- Blood (30 papers)Journal of Clinical Oncology (9 papers)Annals of Hematology (8 papers)Leukemia (6 papers)Cell Death and Disease (5 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Walter E. Aulitzky
146 papers receiving 6.0k citations
Walter E. Aulitzky's Hit Papers
Peers
Comparison fields: 5 of 126
- Hematology 2.5k
- Genetics 1.2k
- Oncology 1.3k
- Pathology and Forensic Medicine 754
- Cancer Research 549
Countries citing papers authored by Walter E. Aulitzky
This map shows the geographic impact of Walter E. Aulitzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter E. Aulitzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter E. Aulitzky more than expected).
Fields of papers citing papers by Walter E. Aulitzky
This network shows the impact of papers produced by Walter E. Aulitzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter E. Aulitzky. The network helps show where Walter E. Aulitzky may publish in the future.
Co-authors
The 25 scholars most cited alongside Walter E. Aulitzky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial Hit paper breakdown → | 2015 | 346 |
| 2 | 2019 | 335 | |
| 3 | 2013 | 277 | |
| 4 | 2017 | 270 | |
| 5 | 2011 | 218 | |
| 6 | 2021 | 192 | |
| 7 | 2012 | 167 | |
| 8 | 2005 | 165 | |
| 9 | 2010 | 155 | |
| 10 | 1997 | 140 | |
| 11 | 2007 | 132 | |
| 12 | 2003 | 129 | |
| 13 | 2007 | 124 | |
| 14 | Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 Hit paper breakdown → | 2024 | 117 |
| 15 | 2003 | 106 | |
| 16 | 2018 | 95 | |
| 17 | 2006 | 94 | |
| 18 | 2011 | 92 | |
| 19 | 2011 | 81 | |
| 20 | 2008 | 80 |
About Walter E. Aulitzky
Walter E. Aulitzky is a scholar working on Hematology, Genetics, Oncology, Immunology and Rheumatology, having authored 151 papers that have together received 6.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (37 papers), Acute Myeloid Leukemia Research (36 papers), Chronic Lymphocytic Leukemia Research (29 papers), Acute Lymphoblastic Leukemia research (14 papers), Eosinophilic Disorders and Syndromes (12 papers), Lymphoma Diagnosis and Treatment (11 papers), Cancer-related Molecular Pathways (10 papers) and Immune Cell Function and Interaction (10 papers). The work is most often cited by research in Hematology (2.5k citations), Genetics (1.2k citations), Oncology (1.3k citations), Pathology and Forensic Medicine (754 citations) and Cancer Research (549 citations). Walter E. Aulitzky has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Heiko van der Kuip, Simon Heine, Justus Duyster, Moshe Oren, Kathrin Böpple, Frank Eßmann, Markus Kleih, Meng Dong, Christian Peschel and Cornelius Miething. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Hematology, Leukemia and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.